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く〉原著 Original Articles 
1) Yang Q., Goto H., Shimada Y., Kita T., Shibahara N. and Terasawa K.: Effects of Choto・san
on hemorheological factors and vascular function in stroke-prone spontaneously hypertensive 
rats. Phytomedicine, 9: 93-98, 2002. 
Abstract: Choto-san is a formula used for the treatment of headache and vertigo. Recently it has often also been 
used for hypertension and dementia. One of the mechanisms involved is thought to be the improvement of blood cirｭ
culation, but the details are stil unclear. In this study, the effect of Chotosan was studied on nitric oxide (NO) funcｭ
tion, hemorheological factors and endothelial function in stroke-prone spontaneously hypertensive rats (SHR-SP). 
Rats were given Choto-san in drinking water for eight weeks. Body weight, blood pressure, serum N02-/N03-, lipid 
peroxides, blood viscosity, erythrocyte deformability and endothelium-dependent／ーindependent relaxation were 
measured. The results indicated that Choto-san caused a decrease in blood pressure and an increase in erythrocyte 
deformability and NO function. Blood viscosity was not changed. Furthermore, endothelium-dependent relaxation 
by acetylcholine was signi白cantly increased as compared to control. In this study, it was supposed that Choto-san 
had a protective effect on the endothelium. SHR国SPis a useful model for human brain stroke, and Choto-san showed 
a protective effect against cerebral vascular injury in the susceptible rat. 
2) Mantani N., Kogure T., Sakai S., Goto H., Shibahara N., Kita T., Shimada Y. and Terasawa 
K.: Incidence and clinical features of liver injury related to Kampo (Japanese herbal) mediｭ
cine in 2,496 cases between 1979 and 1999: problems of the lymphocyte transformation test 
as a diagnostic method. Phytomedicine, 9: 280-287, 2002. 
Abstract: We retrospectively examined the summaries of al admission records of patients from 1979 to 1999 in our 
department, and selected for further study al liver injuries suspected of being related to Kampo medicines. Among 
2,496 summaries, 30 summaries described liver disorders suspected of being related to Kampo medicines. Whether 
there was a causal relationship between the use of Kampo medication and the occu町enceof liver injury was assessed 
according to the criteria described by Haller and Benowitz (2000), independently of the results of the lymphocyte 
transformation test (LTT). Among 30 events, we concluded that 9 were definitely unrelated, and 6 were probably unｭ
related to the use of Kampo medicines. Nine events (0.36% of 2,496 patient admissions and 0.06% of 14,616 out四
patients) were considered possibly related, and only 6 events (0.24% of 2,496 patient admissions and 0.04% of 
14,616 outpatients) were judged to be definitely or probably related to Kampo medicines. Low-grade eosinophilia 
was observed in a few patients of these "related” groups, and no fever or rash was observed in these ”related” groups. 
Other clinical features, including type of liver injury, duration of Kampo medicine-use, recovery period and laboraｭ
tory data, were not different from liver i吋uries associated with western drugs. Most patients in the definitely "unreｭ
lated” group were positive in the LTT for the suspect Kampo medicine, suggesting that the LTT may be unreliable 
for the diagnosis of Kampo-medicine-induced liver injury. From 1979 to 1999, our use of Kampo medicines to treat 
patients resulted in a low rate of liver i吋ury and no fatalities. 
75 
3) Sekiya N., Kogure T., Kita T., Kasahara Y., Sakakibara I., Goto H., Shibahara N., Shimada 
Y. and Terasawa K.: Reduction of pllasma triglyceride level and enhancement of plasma albuｭ
min concentration by Oren-gedoku・to administration. Phytomedicine, 9 : 455-460,2002. 
Abstract: Oren-gedoku-to (Huanglian-Jie-Du-Tang, OGT) has been used for the treatment of cerebrovascular disｭ
ease, hypertension, gastritis and liver disease in Japan. The present study was to test whether ingestion of OGT exｭ
tract (TJ-15) would affect the metabolism of fatty acids and the usual antioxidant molecule (such as albumin, uric 
acid and bilirubin) levels in human plasma. After the administration of TJ-15, plasma total cholesterol and the 
triglyceride level significantly decreased, and lipoprotein lipase mass increased. Significant enhancement of plasma 
albumin level and reduction of the total plasma protein level resulted in an increment of the albumin/globulin ratio. 
Plasma fibrinogen, an independent risk factor for cerebrovascular disease, declined considerably, but the reduction 
was not statistically significant. The findings of this study suggest that ingestion of TJ-15 improves the 
microcirculation through lipid and protein metabolisms, and is useful for the treatment of cerebral vascular attack in 
human. 
4) Sekiya N., Shimada Y., Shibahara N., Takagi S., Yokoyama K., Kasahara Y., Sakakibara I. 
and Terasawa K.: Inhibitory effects of Choto・san (Diao-teng-san), and hooks and stems of 
Uncaria sinensis on free radical-induced Iysis of rat red blood cells. Phytomedicine, 9: 636・
640, 2002. 
Abstract: The present study is designed to test our hypothesis that the ingestion of Uncaria sinensis (US), the main 
medicinal plant of Choto-san (Diao-teng-san, CS), would protect red blood cel (RBC) membrane from free radicalｭ
induced oxidation if polyphenolics in US could be absorbed and circulated in blood. When incubated with RBC susｭ
pension, Choto-san extract (CSE) and Uncaria sinensis extract (USE) exhibited strong protection for RBC membrane 
against hemolysis induced by 2,2-azo-bis (2-amidinopropane) dihydrochloride (AAPH), an azo free-radical initiator. 
The inhibitory effect was dose-dependent at concentrations of 50 to 1000 microg/mL. Ingestion of 200 mg of USE 
was associated with a significant decrease in susceptibility of RBC to hemolysis in rats. Furthermore, caffeic acid, 
an antioxidative hydroxycinnamic acid, was identified in rat plasma after administration of URE. 
5) Sekiya N., Goto H., Shimada Y., Terasawa K.: Inhibitory effects of Keishi-bukuryo・gan on 
free radical induced lysis of rat red blood cells. Phytotherapy Research, 16 : 373・376, 2002. 
Abstract: Keishi-bukuryo-gan (KBG) prevents the progression of atherosclerosis in cholesterol-fed rabbits by its 
antioxidative effect. The present study was to test our hypothesis that ingestion of KBG would protect red blood cel 
(RBC) membranes from free radical induced oxidation if polyphenolic antioxidants in KBG could be absorbed and 
circulated in the blood. When incubated with a RBC suspension, KBG and four of five herb medicines constituting 
KBG provided strong protection for RBC membranes against haemolysis induced by 2,2-azo-bis (2-amidinopropane) 
dihydrochloride (AAPH), an azo free radical initiator. The inhibitory effect was dose dependent at concentrations of 
100-1000 microg/mL. Furthermore, the ingestion of 200 mg of KBG was associated with a significant decrease in 
susceptibility of RBC to haemolysis in rats. 
6) Sekiy~ N. Goto H. Tazawa K. Oida S. Shimada Y. Teirasawa K.: Keishi-bukuryo・gan pre・
serves the endothelium dependent relaxation of thoracic aorta in cholesterol-fed rabbit by 
limiting superoxide generation. Phytotherapy Research, 16: 524-528, 2002. 
Abstract: Formerly, we have reported that keishi-bukuryo-gan prevents the progression of atherosclerosis in cholesｭ
terol-fed rabbits and inhibits the free radical-induced RBC haemolysis in rats.The present study was performed to 
investigate how keishi-bukuryo-gan (KBG) inhibits the early stage of atherosclerosis. Plasma lipid concentration and 
hydroxyl radical generation during respiratory burst in neutrophils were evaluated at the start and end of the study. 
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The protective effect of KBG against endothelium disorder due to hypercholesterolaemia was examined. Twelve 
male Japanese white rabbits (2 kg body weight) were divided into two groups. Group A (n = 6)was fed standard 
rabbit chow containing 1 % cholesterol for 4 weeks. Group B (n = 6) was fed standard rabbit chow containing I% 
cholesterol and 1 % KBG for 4 weeks. In the plasma lipid concentration, only the lipid peroxide concentration of 
group A was significantly higher than that of group B. At the end of the study, DMPO-OH, the spin-trapped adduct 
of hydroxyl radicals generated by neutrophils, was increased in both groups, and this increase was marked in group 
B. Endothelium-dependent vasodilatation by acetylcholine increased significantly in group B compared with group 
A. Thus, KBG protects the vascular endothelium function by its antioxidative effect and by inhibiting the release of 
free radicals from neutrophils in vivo. 
7) Kogure T., Mantani N., Goto H., Shimada Y., Tamura J. and Terasawa K.: The effect of 
interleukin-15 on the expression of killer-cell immunoglobulin-Iike receptors on peripheral 
natural killer cells in human. Mediators of Inflammation, 11 ｷ:219・224, 2002. 
Abstract: Interleukin (IL)-15 has emerged as a key regulator of both natural killer (NK) cel differentiation and acｭ
tivation. The aim of the present study was to investigate the expansion of the population of cells expressing kilerｭ
cel immunoglobulin-like receptors (CD158a and CD158b) in human peripheral lymphocytes by treatment with IL唱
15. One million peripheral lymphocytes were cultured in RPMI1640 medium alone or in medium containing IL-2 
at 100 U/ml or IL-15 at 0.1, 1.0, or 10.0 ng/ml for 48 h. After each incubation, we assessed the natural killing acｭ
tivity and the population of CD16(+)CD158a(+)/b(+) cells and CD8(+)CD158a(+)/b(+) cels. IL-15 increased the 
NK activity and expanded the populations of CD16(+)CD158a(+)/b(+) cells and CD8(+)CD158a(+)/b(+) cels. 
These actions were dose dependent, and the effects of IL-15 at 1.0 ng/ml were close to those of IL~2 at 100 U/ml. 
These findings suggest that IL・ 15 induces the effector functions of resting NK cells throughout the body, and thereby 
plays a critical role in the activation of tissue-associated immune responses. 
8 ) Shimada Y .,Yokoyama Y .,Goto H., Sakakibara I., Seki ya N .,Mantani N .,Sakai S., and 
Terasawa K.: Protective e首ect of the hooks and stems of Uncaria sinensis against nitric oxide 
donor-induced neuronal death in cultured cerebellar granule cells. J. Trad. Med., 19 : 15・20,
2002. 
Abstract: We have previously shown that an aqueous extract of the hooks and stems of Uncaria sinensis (Ouv.) 
HA VIIL., Uncariae Uncus Cum Ramulus, protects against glutamate-induced neuronal death in vitro. Nitric oxide 
(NO) free radicals are also implicated in the process of neuronal death. In this study, we investigated the protective 
effects of Uncaria sinensis extract (USE) and its phenolic and alkaloid fractions against NO donors, sodium 
nitroprusside (SNP) and 3-morpholinosydnonimine (SlN-1), -induced neuronal death in cultured rat cerebellar granｭ
ule cels. MTT assay showed cell viability to be significantly increased by the addition of USE (10, 30 and 100 I 
ｵg/ml) comp訂ed with exposure (6, 12 and 24 h) to SNP (30ｵM) only, and by the addition of USE (10 and 30ｵ 
g/ml) compared with exposure (6, 12 and 24 h) to SIN-1 (300ｵM) only. Phenolic fraction of USE (10 and 30 Iｵ 
g/ml) significantly protected against SNP (30 Iｵ M, 24 hr）ーinduced cel death, and 3 and 10 Iｵ g/ml of this fraction 
significantly protected against SlN-1 (300ｵM, 24 hr)-induced cell death. Alkaloid fraction of USE (30 and 100 I 
ｵ g/ml) significantly protected against SNP (30ｵM, 24 hr) and SIN-1 (300ｵM, 24 hr）ーinduced cel death. These re ” 
sults appear to indicate that Uncaria sinensis has a protective effect against NO-mediated neuronal death in cultured 
cerebellar granule cells and that its active components are included in phenolic and alkaloid fractions. 
9 ) Goto H., Shimada Y.，民rfitsuma T., Shintani T., Nagasaka K., Goto S., Shibahara N. and 
Terasawa K.: E町ect of Keishi-bukuryo・gan on asymptomatic cerebral infarction for short 
term. J. Trad. Med., 19: 46・50, 2002. 
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Abstract: The efficacy of Keishi-bukuryo-gan in patients suffering from asymptomatic cerebral infarction was studｭ
ied. 142 patients, 32 males and 110 females, with a mean age of 68.9 ye紅s, were enrolled and analyzed, and 139 
completed the study. They were given Keishi-bukuryo-gan extract (7.5g/day) three times a day for 12 weeks. In 
comparison to the beginning of the study, Keishi-bukuryo-gan showed improvement with statistical significance in 
the mean revised version of Hasegawa泡 dementia scale, Apathyｷ scale and Self-rating depression scale. The number 
of patients with subjective symptoms as headdullness, headache and dizziness decreased by the treatment with 
Keishi-bukuryo-gan, and diastolic blood pressure was decreased with statistical significance as compared to the beｭ
ginning of the study. These results suggest that Keishi-bukuryo-gan is effective against dysfunction of acknowledgｭ
ment, emotional disorder and subjective symptoms with asymptomatic cerebral infarction. 
10) Kasahara Y., Goto H., Shimada Y., Sekiya N., Yang Q. andTerasawa K.: Inhibitory effects of 
cinnamomi Cortex and cinnamaldehyde on oxygen-derived free radical-induced vasocontracｭ
tion in isolated aorta of spontaneously hypertensive rats. J. Trad. Med., 19 : 51・57, 2002. 
Abstract: We examined the inhibiting effect of Cinnamonti Cortex extract (CCE) and cinnamaldehyde (CA) against 
vasocontraction induced by oxygen-derived free radicals produced by the xanthine-xanthine oxidase (XOD) system 
in the thoracic aortic ring of the spontaneously hypertensive rat (SHR), using the organ bath method in vitro. The 
vasocontraction induced by xanthine-XOD in the CCE 00-4 g/ml) and CA (l0-4 M) treatment groups were signifiｭ
cantly lower than that in the control group. Further, the amounts of throniboxane B2 (TXB2) produced in the 
vasocontractive response in the CCE 00-4 g/ml) and CA 00-4 M) treatment groups were significantly lower than that 
in the control group. For the purpose of examining the mechanism of the inhibiting effect of CA against 
thromboxane production, the inhibiting effect of CA against the vasocontraction induced by phospholipase A2 
(PLA2) was exanrined. The vasocontraction induced by PLA2 in the CA (104 M) treatment group was significantly 
lower than that in the control group. Moreover, the amount of TXB2 produced by the vasocontractive response in 
the CA (lQ-4 M) treatment group was significantly lower than that in the eontrol group. From the above findings, it 
is suggested that Cinnamomi Cortex is an agent which exerts an inhibitory effect on the vasocontractive factor 
(TXA2) in vitro. 
11) Shibahara N., Sekiya N., Sakai S., Goto H., Kita T., Shimada Y., Shintani T. and Terasawa 
K.: Correlation between ” oketsu'' syndrome and autonomic nervous activity -a diachronic 
study in the same subjects ・. J. Trad. Med., 19: 81-86, 2002. 
Abstract: In order to confirm that the autonomic nervous activity changes with the change in the "oketsu” state using 
a diachronic study with the same subjects, 20 patients were evaluated by laser Doppler flowmetry and spectral analyｭ
ses of the R-R intervals (RRs) and systolic blood pressure (SBP). According to the diagnostic criteria of ”oketsu”, 
the ”oketsu” score (OS) was evaluated. After evaluation of OS and measurement of the p訂ameters, each subject unｭ
derwent his own Kampo treatment. Twelve weeks later, OS and the parameters were re-evaluated for each subject. 
The changes in OS and the parameters between week 0 and 12 weeks later were investigated, with the quantity of 
each change being calculated as ムー．ムーSBF showed a significant negative correlation with ムーOS, and ムーRR-L圧f,
ムーSBP-LF and ムーSBP-L/Hrevealed significant positive correlations with ム喝OS. It is known that SBF changes with 
sympathetic nervous activity, and SBP-LF and SBP-L/H reflect a-sympathetic nervous activity. These results suggest 
that the significant relationship between OS and sympathetic nervous activity was maintained even after change in 
the 、ketsu” state in the same subjects. 
12) Mantani N., Sakai S., Kogure T., Goto H., Shibahara N., Kita T., Shimada Y. and Terasawa 
K.: Herbal medicine and false-positive results on lymphocyte transformation test. Yakugaku 
Zasshi ・ Journalof the Pharmaceutical Society of Japan, 122(6): 399-402, 2002. 
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Abstract: In vitro mitogenic activity of 16 herbs and 3 Kampo (herbal medicine) formulae have been reported in exｭ
perimental studies. It is not known how many herbs and Kampo formulae in total have mitogenic activity. 
Lymphocyte transformation test (LTT) is generally utilized to diagnose drug-induced liver injury. In LTT, mitogenic 
activity is assessed by measuring 3H-thymidine incorporation. The objective of the present study was to determine 
which herbs and which Kampo formulae caused false司positivity on LTT. We examined 2496 summaries of al adｭ
mission records from 1979 to 1999 in our department. We selected patients in whom liver injuries were diagnosed 
as definitely unrelated to Kampo medication. In these patients, L TT was performed for some herbs contained in the 
suspect Kampo medicines, resulting in positive L TT for 17 herbs: Evodiae Fructus (Goshuyu), Zizyphi Fructus 
(Taiso ),Ginseng Radix (Ni吋in), Zingiberis Rhizoma (Shokyo), Hoelen (Bukuryo), Aconiti Tuber (Bushi), 
Angelicae Radix (Toki), Cnidii Rhizoma (Senkyu), Rehmanniae Radix (Jio), Ephedrae Herba (Mao), Anemarrhenae 
Rhizoma (Chimo), Cinnamomi Cortex (Keihi), Bupleuri Radix (Saiko), Artemisiae Capillari Spica (lnchinko), 
Persicae Semen (Tonin），加foutan Cortex (Botanpi) and Paeoniae Radix (Shakuyaku). These results were considered 
false-positive, because the results were observed in the ”definitely unrelated” patients. Mitogenic activity inherent to 
some herbs and Kampo formulae may sometimes cause false-positivity on L TT in clinical situations. These examｭ
ples suggest that LTT for Kampo formulae may be unreliable as a diagnostic method for drug-induced liver injury. 
13) Rhyu, D.Y., Yokozawa, T., Cho, E.J., Park, J.C.: Prevention of peroxynitrite-induced renal 
injury through modulation of peroxynitrite production by the Chinese presec1旬tion Wen-Piｭ
Tang. Free Radical Research, 36: 1261-1269, 2002. 
Abstract: The effect of Wen-Pi-Tang extract on renal injury induced by peroxynitrite (ONOO-) production was inｭ
vestigated using rats subjected to intravenous lipopolysaccharide (LPS) i吋ection and then renal ischemia followed 
by reperfusion. The plasma level of 3-nitrotyrosine, a marker of cytotoxic ONOO-formation in vivo, was enhanced 
markedly in control rats subjected to LPS plus ischemia-reperfusion, but was significantly reduced by the oral adｭ
ministration of Wen-Pi-Tang extract, at doses of 62.5 and 125 mg/kg body weight/day, for 30 days prior to LPS plus 
ischemia-reperfusion. The activities of inducible nitric oxide synthase (iNOS) and xanthine oxidase (XOD) in renal 
tissue of control and Wen-Pi-Tang extract-treated rats did not change significantly, while those of the antioxidant enｭ
zymes, superoxide dismutase, catalase and glutathione peroxidase, were significantly increased by the administration 
of Wen-Pi-Tang extract, indicating that Wen-Pi-Tang improved the defense system by scavenging free radicals, not 
by directly inhibiting nitric oxide and superoxide production by iNOS and XOD. In addition, the levels of the 
hydroxylated products, m-and p-tyrosine, declined, whereas that of phenylalanine increased, after oral administraｭ
tion of Wen-Pi-Tang extract. Furthermore, the elevated plasma urea nitrogen and creatinine levels resulting from 
LPS plus ischemia-reperfusion process were significantly reduced by Wen-Pi-Tang extract, implying amelioration 
of renal impairment. The present study indicates that Wen-Pi-Tang extract contributes to the regulation of ONOOｭ
fom'lation and plays a beneficial role against ONOO--induced oxidative injury and renal dysfunction in vivo. 
14) Yokozawa, T., Kim, H.Y., Cho, E.J.: Erythritol attenuates the diabetic oxidative stress 
through modulating glucose metabolism and lipid peroxidation in streptozotocin-induced diaｭ
betic rats. J. Agric. Food Chem., 50: 5485” 5489, 2002. 
Abstract: We investigated the effects of erythritol on rats with streptozotocin-(STZ-) induced diabetes ,mellitus. 
Oral administration of erythritol (100, 200, or 400 mg/kg body weight/ day for IO days] to rats with STZ-induced 
diabetes resulted in significant decreases in the glucose levels of serum, liver, and kidney. Erythritol also reduced 
the elevated serum 5-hydroxymethylfurfural level that is glycosylated with protein as an indicator of oxidative stres. 
In addition, thiobarbituric acid-reactive substance levels of serum and liver and kidney mitochondria were doseｭ
dependently lower in the erythritol-treated groups than in the control diabetic group. Furthermore, the serum 
creatinine level was reduced by oral administration of erythritol in a dose-dependent manner. These results suggest 
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that erythritol affects glucose metabolism and reduces lipid peroxidation, thereby improving the damage caused by 
oxidative stress involved in the pathogenesis of diabetes. 
15) Yokozawa, T., Kim, H.Y., Cho, E.J., Choi, J.S.: Antioxidant effects of isorhamnetin 3, 7・di・
0・β－o-glucopyranoside isolated from mustard leaf (Brassica juncea) in rats with streptozotocinｭ
induced diabetes. J. Agric. Food Chem., 50: 5490-5495, 2002. 
Abstract: To investigate the effects of isorhamnetin 3,7-di-O－ β －D-glucopyranoside (isorhamnetin diglucoside ),a 
m司or flavonoid compound of mustard leaf, on oxidative stress due to diabetes mellitus, in vivo and in vitro studies 
were carried out. Oral administration of isorhamnetin diglucoside (10 or 20 mg/kg of body weight/day for 10 days) 
to ratsｷ with streptozotocin-induced diabetes significantly reduced serum levels of glucose and 5・（hydroxymethyl)
furfural (5-HMF), which is glycosylated with hemoglobin and is an indicator of oxidative stres. After 
intraperitoneal administration, isorhamnetin diglucoside did not show these activities. In addition, after oral adminiｭ
stration, the thiobarbituric acid-reactive substance levels of serum, and liver and kidney mitochondria declined sig‘ 
nificantly compared with the control group in a dose-dependent manner, whereas after intraperitoneal administration 
these levels fel only slightly. On the basis of the oral and intraperitoneal results, it was hypothesized that 
isorhamnetin diglucoside was converted to its metabolite in vivo, and its conversion to its aglycone, isorhamnetin, 
by β －glucosidase was confirmed; isorhamnetin acted as an antioxidant. Moreover, it was observed that isorhamnetin 
diglucoside had no effect on the 1,1-diphenyl-2-picrylhydrazyl radical, whereas isorhamnetin showed a potent antiｭ
oxidant effect in vitro. In addition, intraperitoneal administration of isorhamnetin reduced serum glucose and 5-
HMF levels. Furthermore, lipid peroxidation in blood, liver, and kidney associated with diabetes mellitus declined 
after the administration of isorhamnetin. These results suggest that isorhamnetin diglucoside is metabolized in vivo 
by intestinal bacteria to isorhamnetin and that isorhamnetin plays an important role as an antioxidant. 
16) Yokozawa, T., Kim, H.Y., Cho, E.J., Choi, J.S.: Protective effects of the BuOH fraction from 
mustard leaf in a renal ischemia-reperfusion model. J. Nutr. Sci. Vitaminol., 48 : 384・389,
2002. 
Abstract: The effect of BuOH fraction from mustard leaf in renal ischemic-reperfused rats was examined. The eleｭ
vated serum superoxide anion (02-) level and renal xanthine oxidase (XOD) activity in rats subjected to 6 h 
reperfusion following 1 h ischemia were significantly and dose-dependently declined by the oral administration of 
BuOH fraction from mustard leaf at doses of 50 and 200 mg/kg body weight/day for 10 days prior to ischemiaｭ
reperfusion process. It indicates that BuOH fraction from mustard leaf might scavenge 02-or inhibit the generation 
of 02-by XOD activated through the ischemia-reperfusion process. In addition, thiobarbituric acid-reactive subｭ
stance level in renal mitochondrial fraction was significantly decreased in rats given BuOH fraction orally prior to 
ischemia-reperfusion in comparison with control rats given vehicle instead of BuOH fraction, implying that a protecｭ
tive action against lipid peroxidation caused by ischemia-reperfusion procedure. Furthermore, oral administration of 
BuOH fraction lowered the levels of urea nitrogen and creatinine in serum, indicator of renal function. These results 
suggest that BuOH fraction from mustard leaf has protective effects on ischemia-reperfusion i吋ury playing a role 
as antioxidant through scavenging 02-, inhibiting 02-generation by XOD, protecting against lipid peroxidation and 
improving renal functional impairment. 
17) Liu Y., Cao H., Han G., Fushimi H., Komatsu K.: matK and its nucleotide sequencing of 
crude drug Chuanxiong and phylogenetic relationship between their species from China and 
Japan. Acta Pharmaceutica Sinica., 37 : 63-68, 2002. 
Abstract: AIM: To provide more molecular evidences for species relationship between Chuanxiong (Ligusticum 
chuanxiong Hort.) from China and Japanese Chuanxiong (Senkyu in Japanese) (Cnidium officinale M法ino).
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METHODS: To sequence such two genes as internal transcribed spacer (ITS) from nuclear rDNA and maturase for 
lysine (matK) in tRNA(lys) (UUU) intron 仕om chloroplast DNA of both Ligusticum chuanxiong and Cnidium 
officinale using PCR direct sequencing and to analyze the sequence variation of two genes between these two speｭ
cies. RESULTS: The matK gene sequence of Ligusticum chuanxiong and Cnidium officinale is 1268 bp in length, 
coding 422 amino acids of maturase protein. ITS gene sequence 699 bp, consisting of 54 bp of 18S rRNA-3', 215 
bp of ITSl, 162 bp of 5.8S rRNA, 222 bp of ITS2, 46 bp of 26S rRNA-5'. Multiple sequence alignment shows that 
the sequence of two genes between dried crude drug and fresh voucher material of Ligusticum chuanxiong and 
Cnidium officinale, there is 1 variable site (Tー＞C) in matK (upstream at 595 nt) and ITS (ITS 1 at54 nt) between 
Ligusticum chuanxiong and Cnidium officinale. CONCLUSION: Based on homology analysis of two genes plastid 
matK and nuclear ITS, the origin of Chuanxiong from China and Japan ought to be identical, the scientific name 
Cnidium officinale of Japanese Chuanxiong should be changed to Ligusticum chuanxiong. 
18）喜多敏明，後藤博三，関矢信康，寺津捷年：駆訴を血剤の血清脂質・血液循環に対する影響（基礎）．産
婦人科漢方研究のあゆみ 19: 13・ 18, 2002. 
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cine-Clinical evaluation of the effect of traditional herbal medicines containing Daio (Rhei Rhizoma) on the 
rogression of diabetic nephropathy with overt proteinuria -.J. Trad. Med., 19: 37-45, 2002. 
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